SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $512 | -35.4% | 132,202 | -0.6% | 0.01% | -37.5% |
Q2 2023 | $793 | +82.7% | 133,061 | 0.0% | 0.01% | +100.0% |
Q1 2023 | $434 | -17.3% | 133,061 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $525 | -99.9% | 133,061 | 0.0% | 0.01% | -33.3% |
Q3 2022 | $799,000 | -27.4% | 133,061 | 0.0% | 0.01% | -18.2% |
Q1 2022 | $1,100,000 | -46.6% | 133,061 | 0.0% | 0.01% | -38.9% |
Q4 2021 | $2,059,000 | -24.8% | 133,061 | +9.5% | 0.02% | -30.8% |
Q3 2021 | $2,738,000 | +14.6% | 121,561 | 0.0% | 0.03% | +18.2% |
Q2 2021 | $2,390,000 | -20.2% | 121,561 | +35.8% | 0.02% | -26.7% |
Q1 2021 | $2,995,000 | – | 89,486 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |